Christopher Cleon Rowe
Christopher Cleon Rowe
University of Melbourne
Verified email at austin.org.au
Title
Cited by
Cited by
Year
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines …
RA Sperling, PS Aisen, LA Beckett, DA Bennett, S Craft, AM Fagan, ...
Alzheimer's & dementia 7 (3), 280-292, 2011
52092011
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ...
The Lancet Neurology 13 (6), 614-629, 2014
20532014
NIA‐AA research framework: toward a biological definition of Alzheimer's disease
CR Jack Jr, DA Bennett, K Blennow, MC Carrillo, B Dunn, SB Haeberlein, ...
Alzheimer's & Dementia 14 (4), 535-562, 2018
17102018
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ...
The Lancet Neurology 12 (4), 357-367, 2013
12562013
Imaging β-amyloid burden in aging and dementia
CC Rowe, S Ng, U Ackermann, SJ Gong, K Pike, G Savage, TF Cowie, ...
Neurology 68 (20), 1718-1725, 2007
11092007
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
CC Rowe, KA Ellis, M Rimajova, P Bourgeat, KE Pike, G Jones, J Fripp, ...
Neurobiology of aging 31 (8), 1275-1283, 2010
8762010
β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease
KE Pike, G Savage, VL Villemagne, S Ng, SA Moss, P Maruff, CA Mathis, ...
Brain 130 (11), 2837-2844, 2007
8082007
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
7742015
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ...
Annals of neurology 69 (1), 181-192, 2011
7322011
Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria
B Dubois, H Hampel, HH Feldman, P Scheltens, P Aisen, S Andrieu, ...
Alzheimer's & Dementia 12 (3), 292-323, 2016
6882016
Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism
CC Rowe, U Ackerman, W Browne, R Mulligan, KL Pike, G O'Keefe, ...
The Lancet Neurology 7 (2), 129-135, 2008
6372008
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association
KA Johnson, S Minoshima, NI Bohnen, KJ Donohoe, NL Foster, ...
Journal of Nuclear Medicine 54 (3), 476-490, 2013
5212013
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of …
KA Ellis, AI Bush, D Darby, D De Fazio, J Foster, P Hudson, ...
International psychogeriatrics 21 (4), 672-687, 2009
5022009
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
A Nakamura, N Kaneko, VL Villemagne, T Kato, J Doecke, V Doré, ...
Nature 554 (7691), 249-254, 2018
4822018
Tau imaging: early progress and future directions
VL Villemagne, MT Fodero-Tavoletti, CL Masters, CC Rowe
The Lancet Neurology 14 (1), 114-124, 2015
4032015
Amyloid load in Parkinson’s disease dementia and Lewy body dementia measured with [11C] PIB positron emission tomography
P Edison, CC Rowe, JO Rinne, S Ng, I Ahmed, N Kemppainen, ...
Journal of Neurology, Neurosurgery & Psychiatry 79 (12), 1331-1338, 2008
3972008
Relationship between atrophy and β‐amyloid deposition in Alzheimer disease
G Chételat, VL Villemagne, P Bourgeat, KE Pike, G Jones, D Ames, ...
Annals of neurology 67 (3), 317-324, 2010
3512010
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis
R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ...
Jama 313 (19), 1939-1950, 2015
3392015
Blood-based protein biomarkers for diagnosis of Alzheimer disease
JD Doecke, SM Laws, NG Faux, W Wilson, SC Burnham, CP Lam, ...
Archives of neurology 69 (10), 1318-1325, 2012
3332012
18F-THK523: a novel in vivo tau imaging ligand for Alzheimer’s disease
MT Fodero-Tavoletti, N Okamura, S Furumoto, RS Mulligan, AR Connor, ...
Brain 134 (4), 1089-1100, 2011
3212011
The system can't perform the operation now. Try again later.
Articles 1–20